CAS: 1476074-39-1
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 4-Quinolinecarboxamide, N-methyl-8-[(1S)-1-methyl-2-[(2'-methyl[4,5'-bipyrimidin]-6-yl-4',6'-d2)amino]ethyl]- REF: IN-DA001F09CAS: 1476074-39-1 | % | A consultar | Jue 12 Dic 24 |
 | VX-984 REF: TM-T11067CAS: 1476074-39-1 | 97.65% | 103,00 €~3.597,00 € | Jue 13 Mar 25 |
![4-Quinolinecarboxamide, N-methyl-8-[(1S)-1-methyl-2-[(2'-methyl[4,5'-bipyrimidin]-6-yl-4',6'-d2)...](https://static.cymitquimica.com/products/IN/thumb/DA001F09.jpg)
4-Quinolinecarboxamide, N-methyl-8-[(1S)-1-methyl-2-[(2'-methyl[4,5'-bipyrimidin]-6-yl-4',6'-d2)amino]ethyl]-
CAS:1476074-39-1
Fórmula:
C23H21D2N7O
Pureza:
%
Peso molecular:
415.4873
Ref: IN-DA001F09
| 5mg | 180,00 € | ||
| 10mg | 302,00 € | ||
| 25mg | 567,00 € | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 12 de Diciembre de 2024
VX-984
CAS:1476074-39-1
VX-984 (M9831) is an oral DNA-PK inhibitor, crossing the blood-brain barrier, targeting GBM and NSC-LC.
Fórmula:
C23H21D2N7O
Pureza:
97.65%
Forma y color:
Solid
Peso molecular:
415.49
Ref: TM-T11067
| 1mg | 103,00 € | ||
| 5mg | 256,00 € | ||
| 10mg | 378,00 € | ||
| 25mg | 596,00 € | ||
| 50mg | 804,00 € | ||
| 100mg | 1.078,00 € | ||
| 200mg | 1.452,00 € | ||
| 1mL*10mM (DMSO) | 275,00 € |
Entrega estimada en Estados Unidos, el Jueves 13 de Marzo de 2025
